DALLAH HEALTHCARE COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165.4 SAR | -0.48% |
|
-1.55% | -3.73% |
| Mar. 20 | Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 14 | Dallah Healthcare Logs Higher FY23 Net Profit, Revenue | MT |
Evolution of the average Target Price on Dallah Healthcare Company
Price target over the last 5 years
History of analyst recommendation changes
a7a58fda0fc8492fb2f6eb5c2c08b._Nk_vego-A-63OoGMNY4_t9n_JR0D6aknFIXwc8O8DA.q6116L5Pmz_Oia4xWLl7oYhUuNEOWpTqzxgnrKNnuUWoim_KkX29bP-liQ~f8dfd245e3a0b6fc49dbe98ed02fa2b4
Analysts' Consensus
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
10
Last Close Price
165.4
SAR
Average target price
154.4
SAR
Spread / Average Target
-6.66%
High Price Target
183
SAR
Spread / Highest target
+10.64%
Low Price Target
106
SAR
Spread / Lowest Target
-35.91%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4004 Stock
- Consensus Dallah Healthcare Company
